The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc | COM | 00289Y107 | 5,302 | 369,500 | SH | SOLE | 369,500 | 0 | 0 | ||
Adverum Biotechnologies Inc | COM | 00773U108 | 2,907 | 501,183 | SH | SOLE | 501,183 | 0 | 0 | ||
Allergan PLC | SHS | G0177J108 | 41,840 | 248,620 | SH | SOLE | 248,620 | 0 | 0 | ||
Akorn Inc | COM | 009728106 | 9,439 | 504,503 | SH | SOLE | 504,503 | 0 | 0 | ||
Arrowhead Pharmaceuticals Inc | COM | 04280A100 | 8,033 | 1,114,097 | SH | SOLE | 1,114,097 | 0 | 0 | ||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 16,925 | 484,000 | SH | SOLE | 484,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc | COM | 09061G101 | 21,016 | 259,235 | SH | SOLE | 259,235 | 0 | 0 | ||
BioMarin Pharmaceutical Inc | COM | 09061G101 | 8,731 | 107,700 | SH | Call | SOLE | 107,700 | 0 | 0 | |
Bristol-Myers Squibb Co | COM | 110122108 | 21,657 | 342,399 | SH | SOLE | 342,399 | 0 | 0 | ||
Cara Therapeutics Inc | COM | 140755109 | 4,346 | 351,050 | SH | SOLE | 351,050 | 0 | 0 | ||
Cymabay Therapeutics Inc | COM | 23257D103 | 11,076 | 852,686 | SH | SOLE | 852,686 | 0 | 0 | ||
Catalyst Biosciences Inc | COM NEW | 14888D208 | 13,896 | 538,624 | SH | SOLE | 538,624 | 0 | 0 | ||
Cellectis SA | SPONSORED ADS | 15117K103 | 10,485 | 332,754 | SH | SOLE | 332,754 | 0 | 0 | ||
Clovis Oncology Inc | COM | 189464100 | 12,809 | 242,600 | SH | Call | SOLE | 242,600 | 0 | 0 | |
Corcept Therapeutics Inc | COM | 218352102 | 17,193 | 1,045,196 | SH | SOLE | 1,045,196 | 0 | 0 | ||
Dova Pharmaceuticals Inc | COM | 25985T102 | 15,411 | 568,243 | SH | SOLE | 568,243 | 0 | 0 | ||
FibroGen Inc | COM | 31572Q808 | 6,971 | 150,888 | SH | SOLE | 150,888 | 0 | 0 | ||
Homology Medicines Inc | COM | 438083107 | 243 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
Global Blood Therapeutics Inc | COM | 37890U108 | 15,222 | 315,147 | SH | SOLE | 315,147 | 0 | 0 | ||
Heron Therapeutics Inc | COM | 427746102 | 11,288 | 409,000 | SH | SOLE | 409,000 | 0 | 0 | ||
Immunomedics Inc | COM | 452907108 | 15,799 | 1,081,410 | SH | SOLE | 1,081,410 | 0 | 0 | ||
Insmed Inc | COM PAR $.01 | 457669307 | 20,685 | 918,523 | SH | SOLE | 918,523 | 0 | 0 | ||
Kura Oncology Inc | COM | 50127T109 | 6,599 | 351,955 | SH | SOLE | 351,955 | 0 | 0 | ||
Madrigal Pharmaceuticals Inc | COM | 558868105 | 4,231 | 36,226 | SH | SOLE | 36,226 | 0 | 0 | ||
Menlo Therapeutics Inc | COM | 586858102 | 2,786 | 74,142 | SH | SOLE | 74,142 | 0 | 0 | ||
Mylan NV | SHS EURO | N59465109 | 10,745 | 261,000 | SH | SOLE | 261,000 | 0 | 0 | ||
NewLink Genetics Corp | COM | 651511107 | 3,625 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
OncoSec Medical Inc | COM NEW | 68234L207 | 3,881 | 2,064,297 | SH | SOLE | 2,064,297 | 0 | 0 | ||
Pacira Pharmaceuticals Inc/DE | COM | 695127100 | 14,909 | 478,620 | SH | SOLE | 478,620 | 0 | 0 | ||
Perrigo Co PLC | SHS | G97822103 | 4,646 | 55,748 | SH | SOLE | 55,748 | 0 | 0 | ||
Sage Therapeutics Inc | COM | 78667J108 | 12,600 | 78,227 | SH | SOLE | 78,227 | 0 | 0 | ||
Seattle Genetics Inc | COM | 812578102 | 18,998 | 362,974 | SH | SOLE | 362,974 | 0 | 0 | ||
Sangamo Therapeutics Inc | COM | 800677106 | 14,941 | 786,376 | SH | SOLE | 786,376 | 0 | 0 | ||
Shire PLC | SPONSORED ADR | 82481R106 | 20,846 | 139,543 | SH | SOLE | 139,543 | 0 | 0 | ||
Sol-Gel Technologies Ltd | SHS | M8694L103 | 5,334 | 517,873 | SH | SOLE | 517,873 | 0 | 0 | ||
Stemline Therapeutics Inc | COM | 85858C107 | 8,011 | 523,624 | SH | SOLE | 523,624 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P BIOTECH | 78464A870 | 175,460 | 2,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | |
Xenon Pharmaceuticals Inc | COM | 98420N105 | 1,857 | 379,071 | SH | SOLE | 379,071 | 0 | 0 | ||
Zafgen Inc | COM | 98885E103 | 2,992 | 401,558 | SH | SOLE | 401,558 | 0 | 0 | ||
Zosano Pharma Corp | COM NEW | 98979H202 | 3,528 | 700,000 | SH | SOLE | 700,000 | 0 | 0 |